TURGEON JOSEPH W. (CEO & President) sold 2.3% of their position (14.76K shares) of SPECTRUM PHARMACEUTICALS INC on the open market
Open‑market sale worth $54.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock, $0.001 par value
Shares
+278.09K
Price / share
—
Trade value
—
% of position
Common Stock, $0.001 par value
Shares
−7.26K
Price / share
$3.64
Trade value
$26.39K
% of position
Common Stock, $0.001 par value
Shares
−7.50K
Price / share
$3.73
Trade value
$27.98K
% of position
Net shares
+263.33K
Net value
-$54.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Direct | 2/18/2021 | A · Award | +278.09K | — | — | 75.2% | 370.03K | 648.12K |
| Common Stock, $0.001 par value Direct | 2/19/2021 | S · Sale | −7.26K | $3.64 | $26.39K | 1.1% | 648.12K | 640.86K |
| Common Stock, $0.001 par value Direct | 2/22/2021 | S · Sale | −7.50K | $3.73 | $27.98K | 1.2% | 640.86K | 633.36K |
| Total | +263.33K | -$54.37K | ||||||
Stock Option (Right to Buy)
Common Stock
337.08K shares
Shares
+337.08K
Strike price
3.56
Held after
337.08K
Exercisable
—
Stock Appreciation Right
Common Stock
792.13K shares
Shares
+792.13K
Strike price
3.56
Held after
792.13K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock337.08K shares | 2/18/2021 | A · Award | +337.08K | 3.56 | — | 337.08K |
| Stock Appreciation Right Direct | Common Stock792.13K shares | 2/18/2021 | A · Award | +792.13K | 3.56 | — | 792.13K |
Common Stock, $0.001 par value
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.001 par value | 1.54K | Indirect |
| Total | 1.54K | 1.54K indirect |